1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6366A1F0529B66EA485256DBB00662754
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/profiles-of-in-licensing-organizations-2?opendocument
18
19
20
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » New Product Development » New Product Planning

Profiles of In-Licensing Organizations 2

DB Image

ID: 4496


Features:

Graphics, Summary Matrix, Detailed Process Map


Words: 2,698


Published: Pre-2018


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 16-page document profiles in-licensing organizations at five leading pharmaceutical companies. Each profile provides an in-depth discussion of strategy, structure, core group staffing, evaluation and licensing process, and other critical factors for this area of business development. These criteria are augmented with organization charts and process maps, all of which provide clear insights on how to develop effective in-licensing organizations. This document originated from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Health Care; Chemical


Companies Profiled:
AstraZeneca; Sanofi-aventis; Roche; Johnson & Johnson; Novartis; GlaxoSmithKline; Genentech; Bristol-Myers Squibb

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.